日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.

SV2A PET 显示出实验性自身免疫性脑脊髓炎和多发性硬化症初步研究中的突触密度损失。

Chia Pou Hong Justin, Toyonaga Takuya, Tong Junchao, Le Hannah, Dias Mark, Boyle Amanda J, Raymond Roger, Longbrake Erin E, Huang Yiyun, Carson Richard E, Airas Laura, Vasdev Neil, Chen Ming-Kai, Zheng Chao

Comparing kinetic profiles of SV2A radiotracers [(18)F]SynVesT-1 and [(18)F]UCB-J using PET imaging in mice

利用PET成像技术在小鼠体内比较SV2A放射性示踪剂[(18)F]SynVesT-1和[(18)F]UCB-J的动力学特征

Everix, Liesbeth; Miranda, Alan; Akkermans, Jordy; Khetarpal, Vinod; Liu, Longbin; Bard, Jonathan; Staelens, Steven; Bertoglio, Daniele

High-resolution in utero SV2A PET imaging of the nonhuman primate brain using the NeuroEXPLORER

利用NeuroEXPLORER对非人灵长类动物大脑进行高分辨率子宫内SV2A PET成像

Mehta, Saloni; Sun, Huili; Micali, Nicola; Holden, Daniel; Fowles, Krista; Rossano, Samantha; Zhang, Jiazhen; Ma, Chao; Han, Paul; Lee, Wonil; Duque, Alvaro; Rakic, Pasko; Groman, Stephanie M; Carson, Richard E; Scheinost, Dustin; Toyonaga, Takuya

Structural pharmacology of SV2A reveals an allosteric modulation mechanism in the major facilitator superfamily

SV2A的结构药理学揭示了主要促进因子超家族中的变构调节机制

Pidathala, Shabareesh; Chen, Xiao; Dai, Yaxin; Nguyen, Long N; Gorgulla, Christoph; Niu, Yiming; Liu, Fangyu; Lee, Chia-Hsueh

Structures of native SV2A reveal the binding mode for tetanus neurotoxin and anti-epileptic racetams

天然SV2A的结构揭示了破伤风神经毒素和抗癫痫药物吡拉西坦的结合模式

Schenck, Stephan; Laeremans, Toon; Steyaert, Jan; Brunner, Janine D

Targeting ROCK2 to Restore Epileptic Synaptic Networks via Mitophagy Activation: Insights from Translational Imaging of SV2A In Vivo

通过线粒体自噬激活靶向 ROCK2 以恢复癫痫突触网络:来自体内 SV2A 转化成像的启示

Xiao, Ling; Wang, Jing; Chen, Bei; Yang, Jinhui; Wu, Fangyu; Zhou, Chunyao; Zhang, Yifei; Yang, Zhiquan; Liu, Dingyang; Tian, Lei; Yu, Jianhua; Han, Fei; Tang, Yongxiang; Feng, Li; Hu, Shuo

Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)

抗癫痫药物与突触囊泡蛋白2A (SV2A) 结合的变构调节机制

Mittal, Anshumali; Martin, Matthew F; Provins, Laurent; Hall, Adrian; Ledecq, Marie; Wolff, Christian; Gillard, Michel; Horanyi, Peter S; Coleman, Jonathan A

The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study

精神分裂症早期皮质突触末端密度标志物SV2A与谷氨酸的关系:一项多模态PET和MRS成像研究

Onwordi, Ellis Chika; Whitehurst, Thomas; Shatalina, Ekaterina; Carr, Richard; Mansur, Ayla; Arumuham, Atheeshaan; Osugo, Martin; Marques, Tiago Reis; Jauhar, Sameer; Gupta, Susham; Pappa, Sofia; Mehrotra, Ravi; Ranger, Maja; Rahaman, Nikola; Rabiner, Eugenii A; Gunn, Roger N; Natesan, Sridhar; Howes, Oliver D

Preclinical validation and kinetic modelling of the SV2A PET ligand [(18)F]UCB-J in mice

SV2A PET 配体 [(18)F]UCB-J 在小鼠体内的临床前验证和动力学建模

Everix, Liesbeth; Elvas, Filipe; Miranda Menchaca, Alan; Khetarpal, Vinod; Liu, Longbin; Bard, Jonathan; Staelens, Steven; Bertoglio, Daniele

Control of Synaptotagmin-1 Trafficking by SV2A-Mechanism and Consequences for Presynaptic Function and Dysfunction

SV2A机制对突触结合蛋白-1转运的控制及其对突触前功能和功能障碍的影响

Hogg, James A; Cousin, Michael A